New technology finds patients who are more likely to face lethal arrythmias
When electrical waves in the heart run amok in a condition called arrhythmia, sudden death can occur. To save the life of a patient at risk, doctors currently implant a small defibrillator to sense the onset of arrhythmia and jolt the heart back to a normal rhythm. But a thorny question remains: How should doctors decide which patients truly need an invasive, costly electrical implant that is not without health risks of its own?
Registration is now open for the National Academies of Sciences public workshop on Strategies to Improve Cardiac Arrest Survival on July 11-12 in Washington, D.C. The Sudden Cardiac Arrest Foundation is a meeting sponsor. More...
See attached agenda.
The meeting is free and open to the public, but registration is required. To register, click here.
PHOENIX, AZ--The implementation of a Telephone Cardiopulmonary Resuscitation (TCPR) program increases survival rates and favorable outcomes for patients who experienced an out-of-hospital cardiac arrest, according to a University of Arizona Department of Emergency Medicine study published online in JAMA Cardiology.
A message from Maxwell King, CEO of The Pittsburgh Foundation
PITTSBURGH, PA--"The Pittsburgh Foundation’s Day of Giving program, which in its six years of operation has raised more than $40 million for worthy nonprofits through a combination of individual donations and generous match pooling, has now been forced to suspend operation of today’s event.
The decision was made this afternoon after the national online fundraising firm’s technology platform used by 54 participating community foundations across the country had technical problems that severely disrupted the ability of tens of thousands of donors to complete transactions on coordinating organizations’ websites such as our PittsburghGives.org portal.
PITTSBURGH, PA--The Sudden Cardiac Arrest Foundation today achieved the Silver GuideStar Nonprofit Profile level. GuideStar is the world’s largest source of information about nonprofit organizations and a leader in advancing transparency in the nonprofit sector. This level demonstrates the Sudden Cardiac Arrest Foundation's deep commitment to nonprofit transparency and accountability.
Young athletes should not undergo screening to prevent sudden cardiac arrest because it is not proven to save lives, suggests an analysis of the available evidence published in The British Medical Journal today.
The findings show that the harms outweigh any benefits, and no robust evidence exists to confirm it actually prevents deaths.
"Sudden cardiac death of a young person on a sports field is a devastating event," explain the authors from the Belgian Health Care Knowledge Centre.
They estimate that around 0.001% of young athletes die suddenly from sudden cardiac arrest every year, often caused by an underlying cardiovascular condition.
PITTSBURGH, PA--The inaugural Steel City Fire on Ice Charity Classic will take place on Saturday, June 25, at the Robert Morris Island Sports Center in Pittsburgh. Pittsburgh area firefighters and firefighters from Johnstown, PA, will compete in a hockey game to raise funds for the Sudden Cardiac Arrest Foundation, a national non-profit organization based in Pittsburgh. The faceoff will take place at 7:00 pm.
Prior to the game, from 5:00-7:00 pm, there will be a meeting of the Southwestern PA Affiliate of the Sudden Cardiac Arrest Foundation. Survivors, their loved ones, and other advocates are encouraged to attend. CPR-AED demonstrations will be provided for the public.
Cardiac arrest can strike a seemingly healthy individual of any age at any time, often without warning. Each year, more than half a million people in the United States experience a cardiac arrest. Using conservative estimates, it is the third leading cause of death, following cancer and heart disease, although more complete data is needed.
CHELMSFORD, MA--ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that the American Heart Association (AHA), with the endorsement of the Heart Rhythm Society (HRS), has issued a Science Advisory providing recommendations for use of the wearable cardioverter defibrillator (WCD) in clinical practice. The AHA and HRS recommend that the WCD may be considered for a wide range of patients at risk of sudden cardiac death (SCD), including those who have recently suffered a myocardial infarction (MI), with or without revascularization, and those with a newly diagnosed non-ischemic dilated cardiomyopathy.